Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Alario

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Bollettino Dell'Istituto Sieroterapico Milanese|July 31, 1979
[Diffusion of hepatitis B surface antigens in subjects with bladder schistosomiasis]M Nuti, S Abdullahi Elmi, C Alario
Clinical and Experimental Immunology|April 7, 1998
The Italian quality control study for evaluation of CD4 cells in centres involved in the treatment of HIV-1 patients. Italian CD4 Quality Control GroupF Pandolfi, C Alario, E Girardi, et al.
Journal of Biological Regulators and Homeostatic Agents|April 14, 2000
Evaluation of T-cell response to CD3 plus CD28 monoclonal antibodies in HIV-1 infected subjects treated with highly active antiretroviral therapyM Carlesimo, M L Bernardi, G Mattiacci, et al.
Human Immunology|January 5, 2002
Distribution of the natural killer-related receptor for HLA-C during highly active antiretroviral therapy for human immunodeficiency virus infectionM C Sirianni, F Ensoli, C Alario, et al.
HIV Medicine|May 16, 2002
Endogenous cytokine production protects T cells from spontaneous apoptosis during highly active antiretroviral therapyF Ensoli, V Fiorelli, M De Cristofaro, et al.
AIDS (London, England)|July 23, 1999
Long-term evaluation of T-cell subsets and T-cell function after HAART in advanced stage HIV-1 diseaseI Mezzaroma, M Carlesimo, E Pinter, et al.
AIDS Research and Human Retroviruses|October 29, 2000
Recovery of hematopoietic activity in bone marrow from human immunodeficiency virus type 1-infected patients during highly active antiretroviral therapyA Isgrò, I Mezzaroma, A Aiuti, et al.
Clinical Immunology (Orlando, Fla.)|September 22, 2000
Decreased T cell apoptosis and T cell recovery during highly active antiretroviral therapy (HAART)F Ensoli, V Fiorelli, C Alario, et al.
The Journal of Infectious Diseases|October 23, 1997
Long-term evaluation of cellular immunity during antiretroviral therapy and immunization with human immunodeficiency virus type 1 (HIV-1) Env glycoprotein in HIV-1-infected personsM Carlesimo, O Pontesilli, E C Guerra, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Bollettino Dell'Istituto Sieroterapico Milanese|July 31, 1979
[Diffusion of hepatitis B surface antigens in subjects with bladder schistosomiasis]M Nuti, S Abdullahi Elmi, C Alario
Clinical and Experimental Immunology|April 7, 1998
The Italian quality control study for evaluation of CD4 cells in centres involved in the treatment of HIV-1 patients. Italian CD4 Quality Control GroupF Pandolfi, C Alario, E Girardi, et al.
Journal of Biological Regulators and Homeostatic Agents|April 14, 2000
Evaluation of T-cell response to CD3 plus CD28 monoclonal antibodies in HIV-1 infected subjects treated with highly active antiretroviral therapyM Carlesimo, M L Bernardi, G Mattiacci, et al.
Human Immunology|January 5, 2002
Distribution of the natural killer-related receptor for HLA-C during highly active antiretroviral therapy for human immunodeficiency virus infectionM C Sirianni, F Ensoli, C Alario, et al.
HIV Medicine|May 16, 2002
Endogenous cytokine production protects T cells from spontaneous apoptosis during highly active antiretroviral therapyF Ensoli, V Fiorelli, M De Cristofaro, et al.
AIDS (London, England)|July 23, 1999
Long-term evaluation of T-cell subsets and T-cell function after HAART in advanced stage HIV-1 diseaseI Mezzaroma, M Carlesimo, E Pinter, et al.
AIDS Research and Human Retroviruses|October 29, 2000
Recovery of hematopoietic activity in bone marrow from human immunodeficiency virus type 1-infected patients during highly active antiretroviral therapyA Isgrò, I Mezzaroma, A Aiuti, et al.
Clinical Immunology (Orlando, Fla.)|September 22, 2000
Decreased T cell apoptosis and T cell recovery during highly active antiretroviral therapy (HAART)F Ensoli, V Fiorelli, C Alario, et al.
The Journal of Infectious Diseases|October 23, 1997
Long-term evaluation of cellular immunity during antiretroviral therapy and immunization with human immunodeficiency virus type 1 (HIV-1) Env glycoprotein in HIV-1-infected personsM Carlesimo, O Pontesilli, E C Guerra, et al.
Pageof 1